IMMUNOModel COST Action

Modelling immunotherapy response and toxicity in cancer
The COST Action IMMUNO-model CA21135 aims to foster research and innovation in the field of preclinical immuno-oncology models with the ultimate goal of advancing in the treatment of cancer patients by improving their outcomes and quality of life.